LG Chem Launches Zemidapa Thailand, a Diabetes Treatment Complex...Targeting the global market in earnest
May 09, 2025
|
Zemidapa is a combination of the first domestic diabetes treatment drug, the DPP-4 inhibitor 'Zemiglo' and the SGLT-2 inhibitor component 'Dapagliflozin'.
LG Chem announced that it held a symposium 'Zemi-CONNECT Global' for 120 endocrinologists from Korea, Thailand, and the Philippines in Bangkok, Thailand, to announce the launch of Zemi-CONNECT Thailand and its global business plan. The event was held during the schedule of the International Diabetes Federation (IDF) 2025 General Assembly, where LG Chem participated as the main sponsor.
According to IQVIA MIDAS, a pharmaceutical market research firm, the total market size of Thailand's DPP-4 inhibitor and SGLT-2 inhibitor-based products in 2024 is about 250 billion won, especially the composite drug market of the two affiliates, which has grown 36% annually over the past three years.
LG Chem said it is meaningful that it has entered the complex market for the second time and laid the foundation for preoccupying the market.
LG Chem is planning to create business synergies by utilizing the Gemiglo and Gemimet sales networks established in Thailand. The company plans to expand its Thai business performance by providing a wider range of prescription options following the launch of Jemidapa, local academic marketing, and strengthening its customer network. Gemiglo and Gemimet's market share in the Thai market (DPP-4 inhibitor market) last year was about 13%, establishing themselves as leading products to lead the growth of the Thai diabetes market.
LG Chem plans to continue its export of Zemidapa to the Philippines, Mexico, and Brazil.
Hwang In-cheol, head of LG Chem's primary-care business division, said, `As the importance of managing young-onset diabetics (YOD) is increasing in Thailand, the demand for complex drugs with strong blood sugar-lowering effects such as Zemidapa and Zemidamet is expected to continue to grow.'"We will expand our business performance in ASEAN and Latin American markets, starting with our entry into Zemidamapa Thailand."
This article was translated by Naver AI translator.
